Visualization of Polarized Membrane Type 1 Matrix Metalloproteinase Activity in Live Cells by Fluorescence Resonance Energy Transfer Imaging*

Membrane type 1 matrix metalloproteinase (MT1-MMP) plays a critical role in cancer cell biology by proteolytically remodeling the extracellular matrix. Utilizing fluorescence resonance energy transfer (FRET) imaging, we have developed a novel biosensor, with its sensing element anchoring at the extracellular surface of cell membrane, to visualize MT1-MMP activity dynamically in live cells with subcellular resolution. Epidermal growth factor (EGF) induced significant FRET changes in cancer cells expressing MT1-MMP, but not in MT1-MMP-deficient cells. EGF-induced FRET changes in MT1-MMP-deficient cells could be restored after reconstituting with wild-type MT1-MMP, but not MMP-2, MMP-9, or inactive MT1-MMP mutants. Deletion of the transmembrane domain in the biosensor or treatment with tissue inhibitor of metalloproteinase-2, a cell-impermeable MT1-MMP inhibitor, abolished the EGF-induced FRET response, indicating that MT1-MMP acts at the cell surface to generate FRET changes. In response to EGF, active MT1-MMP was directed to the leading edge of migrating cells along micropatterned fibronectin stripes, in tandem with the local accumulation of the EGF receptor, via a process dependent upon an intact cytoskeletal network. Hence, the MT1-MMP biosensor provides a powerful tool for characterizing the molecular processes underlying the spatiotemporal regulation of this critical class of enzymes.

[1]  D. Gingras,et al.  Src-dependent Phosphorylation of Membrane Type I Matrix Metalloproteinase on Cytoplasmic Tyrosine 573 , 2007, Journal of Biological Chemistry.

[2]  María C Montoya,et al.  MT1‐MMP proinvasive activity is regulated by a novel Rab8‐dependent exocytic pathway , 2007, The EMBO journal.

[3]  Shaoqun Zeng,et al.  Detection of MMP activity in living cells by a genetically encoded surface-displayed FRET sensor. , 2007, Biochimica et biophysica acta.

[4]  Steven C George,et al.  Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. , 2006, Tissue engineering.

[5]  E. Génot,et al.  Transforming Growth Factor β Induces Rosettes of Podosomes in Primary Aortic Endothelial Cells , 2006, Molecular and Cellular Biology.

[6]  Peter Friedl,et al.  Molecular mechanisms of cancer cell invasion and plasticity , 2006, The British journal of dermatology.

[7]  R. Tsien,et al.  The Fluorescent Toolbox for Assessing Protein Location and Function , 2006, Science.

[8]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[9]  A. Strongin,et al.  The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP) , 2005, Journal of Cell Science.

[10]  Keith A. Lidke,et al.  Reaching out for signals , 2005, The Journal of cell biology.

[11]  Bin Nan,et al.  Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. , 2005, Cancer research.

[12]  J. Guan,et al.  FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. , 2005, Developmental cell.

[13]  Elliot L. Botvinick,et al.  Visualizing the mechanical activation of Src , 2005, Nature.

[14]  S. Weiss,et al.  An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature. , 2005, Genes & development.

[15]  Patrick S Daugherty,et al.  Evolutionary optimization of fluorescent proteins for intracellular FRET , 2005, Nature Biotechnology.

[16]  K. Beningo,et al.  Responses of fibroblasts to anchorage of dorsal extracellular matrix receptors , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Gingras,et al.  Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase* , 2004, Journal of Biological Chemistry.

[18]  Steven Shapiro,et al.  Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP , 2004, The Journal of cell biology.

[19]  Christopher S. Chen,et al.  Simple approach to micropattern cells on common culture substrates by tuning substrate wettability. , 2004, Tissue engineering.

[20]  A. Miyawaki,et al.  Expanded dynamic range of fluorescent indicators for Ca(2+) by circularly permuted yellow fluorescent proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. Broaddus,et al.  Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. , 2004, Neuro-oncology.

[22]  L. Moro,et al.  Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses. , 2004, Biochemical Society transactions.

[23]  L. Addadi,et al.  Hierarchical assembly of cell-matrix adhesion complexes. , 2004, Biochemical Society transactions.

[24]  K. Hahn,et al.  Designing biosensors for Rho family proteins — deciphering the dynamics of Rho family GTPase activation in living cells , 2004, Journal of Cell Science.

[25]  Richard G. W. Anderson,et al.  Integrins Regulate Rac Targeting by Internalization of Membrane Domains , 2004, Science.

[26]  A. Strongin,et al.  Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells. , 2004, Experimental cell research.

[27]  T. O'brien,et al.  The novel serine protease tumor‐associated differentially expressed gene–15 (matriptase/MT‐SP1) is highly overexpressed in cervical carcinoma , 2003, Cancer.

[28]  J. Brugge,et al.  Src kinase activation by direct interaction with the integrin β cytoplasmic domain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[30]  Motoharu Seiki,et al.  Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. , 2003, Cancer letters.

[31]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[32]  S. Zucker,et al.  Rapid Trafficking of Membrane Type 1-Matrix Metalloproteinase to the Cell Surface Regulates Progelatinase A Activation , 2002, Laboratory Investigation.

[33]  H. Mori,et al.  CD44 directs membrane‐type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin‐like domain , 2002, The EMBO journal.

[34]  Nasreen S Jessani,et al.  Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Weiss,et al.  Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent Processes , 2002, The Journal of experimental medicine.

[36]  Hiroshi Ohno,et al.  Cytoplasmic tail–dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity , 2001, The Journal of cell biology.

[37]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[38]  Stephen J. Weiss,et al.  Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Juan P. Albar,et al.  Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling* , 2001, The Journal of Biological Chemistry.

[40]  Hiroshi Sato,et al.  Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion , 2001, The EMBO journal.

[41]  Jeffrey W. Smith,et al.  MT1-MMP Initiates Activation of pro-MMP-2 and Integrin αvβ3 Promotes Maturation of MMP-2 in Breast Carcinoma Cells , 2001 .

[42]  H. Steven Wiley,et al.  Regulation of Receptor Tyrosine Kinase Signaling by Endocytic Trafficking , 2001, Traffic.

[43]  D. Ruiter,et al.  Expression of integrin αvβ3 correlates with activation of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) and matrix metalloproteinase‐2 (MMP‐2) in human melanoma cells in vitro and in vivo , 2000 .

[44]  J. Keski‐Oja,et al.  Regulation of Membrane-type-1 Matrix Metalloproteinase Activity by Its Cytoplasmic Domain* , 2000, The Journal of Biological Chemistry.

[45]  G. Giannelli,et al.  Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5 , 2000, The Journal of cell biology.

[46]  D. Lauffenburger,et al.  Shaping up for shipping out: PLCgamma signaling of morphology changes in EGF-stimulated fibroblast migration. , 1999, Cell motility and the cytoskeleton.

[47]  H. Sato,et al.  Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts , 1999, British Journal of Cancer.

[48]  A. Sorkin,et al.  Endocytosis of Functional Epidermal Growth Factor Receptor-Green Fluorescent Protein Chimera* , 1998, The Journal of Biological Chemistry.

[49]  Jennifer Lippincott-Schwartz,et al.  Insights into secretory and endocytic membrane traffic using green fluorescent protein chimeras , 1997, Current Opinion in Neurobiology.

[50]  W. T. Chen,et al.  Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  V. Kinzel,et al.  Signal transduction through epidermal growth factor receptor is altered in HeLa monolayer cells during mitosis. , 1997, The Biochemical journal.

[52]  M. C. Ovejero,et al.  Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. , 1997, Journal of cell science.

[53]  K. Yamada,et al.  Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors , 1996, The Journal of cell biology.

[54]  H. Sato,et al.  Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. , 1996, Cancer research.

[55]  Stephen J. Weiss,et al.  Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.

[56]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[57]  Y. Chiew,et al.  Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. , 1992, The Journal of biological chemistry.

[58]  M. Maa,et al.  Functional implication of the interaction between EGF receptor and c-Src. , 2003, Frontiers in bioscience : a journal and virtual library.